Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| CEO | | 1.38M | $19.32M | - |
| CEO | Indig Chaim | 1.36M | $19.02M | -21,073 |
| Pres | Roberts Evan | 826.6K | $11.55M | -14,395 |
| Pres | | 790.9K | $11.05M | - |
| Pres | | 237.8K | $3.32M | - |
Transactions
29 transactions · page 10
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2020-12-24 | CAHILL EDWARD L | Director | Sell | 24,370 | $57.22 | $1,394,480.64 | -25.6% | → |
| 2020-12-17 | Pegus Cheryl | Director | Sale+OE | 31,147 | $55.91 | $1,741,581.07 | -42.6% | → |
| 2020-10-23 | Altier Thomas | Chief Financial Officer | Sale+OE | 94,906 | $37.70 | $3,577,754.04 | -22.8% | → |
| 2020-10-21 | VanDuyn Amy Beth | SVP, Human Resources | Sale+OE | 10,834 | $35.00 | $379,190.00 | -17.6% | → |
| 2020-10-12 | Altier Thomas | Chief Financial Officer | Sale+OE | 6,779 | $32.13 | $217,778.76 | -4.1% | → |
| 2020-10-01 | Linetsky David | SVP, Life Sciences | Sale+OE | 4,477 | $30.97 | $138,667.24 | -1.7% | → |
| 2020-10-01 | Roberts Evan | Chief Operating Officer | Sell | 14,774 | $30.93 | $456,952.43 | -2.1% | → |
| 2020-09-11 | Altier Thomas | Chief Financial Officer | Sale+OE | 6,779 | $27.99 | $189,712.34 | -2.9% | → |
| 2020-08-17 | Kallenbach Charles | General Counsel & Secretary | Sale+OE | 2,500 | $29.84 | $74,593.00 | -6.0% | → |
| 2020-08-11 | Altier Thomas | Chief Financial Officer | Sale+OE | 6,779 | $30.10 | $204,035.21 | -2.9% | → |
| 2020-08-10 | Smith Mark Douglas | Director | Sale+OE | 6,000 | $30.30 | $181,824.60 | -49.5% | → |
| 2020-07-31 | Nathan Daniel | Chief Technology Officer | Sale+OE | 8,804 | $30.03 | $264,391.16 | -13.5% | → |
| 2020-07-21 | CAHILL EDWARD L | Director | Sell | 9,080 | $29.02 | $263,519.76 | -16.3% | → |
| 2020-07-17 | Kallenbach Charles | General Counsel & Secretary | Sale+OE | 2,500 | $29.29 | $73,233.50 | -6.0% | → |
| 2020-07-17 | Nathan Daniel | Chief Technology Officer | Sale+OE | 38,683 | $29.25 | $1,131,431.33 | -82.9% | → |
| 2020-07-01 | Roberts Evan | Chief Operating Officer | Sell | 12,500 | $28.45 | $355,622.50 | -1.8% | → |
| 2020-07-01 | Linetsky David | SVP, Life Sciences | Sale+OE | 4,475 | $28.24 | $126,395.93 | -3.3% | → |
| 2020-06-17 | Kallenbach Charles | General Counsel & Secretary | Sale+OE | 2,500 | $29.26 | $73,145.25 | -6.0% | → |
| 2020-06-12 | Munson Gillian | Director | Sell | 5,000 | $28.32 | $141,600.00 | -23.8% | → |
| 2020-05-18 | Kallenbach Charles | General Counsel & Secretary | Sale+OE | 2,500 | $27.20 | $68,000.00 | -6.0% | → |
| 2020-05-07 | Linetsky David | SVP, Life Sciences | Sell | 255 | $26.00 | $6,630.00 | -0.2% | → |
| 2020-05-01 | Altier Thomas | Chief Financial Officer | Sell | 1,096 | $24.34 | $26,673.79 | -0.9% | → |
| 2020-05-01 | VanDuyn Amy Beth | SVP, Human Resources | Sale+OE | 13,474 | $24.88 | $335,186.00 | -12.1% | → |